DK3581645T3 - Fremgangsmåde til at fremme diversifikation af en antistof variabel region - Google Patents

Fremgangsmåde til at fremme diversifikation af en antistof variabel region Download PDF

Info

Publication number
DK3581645T3
DK3581645T3 DK18750887.4T DK18750887T DK3581645T3 DK 3581645 T3 DK3581645 T3 DK 3581645T3 DK 18750887 T DK18750887 T DK 18750887T DK 3581645 T3 DK3581645 T3 DK 3581645T3
Authority
DK
Denmark
Prior art keywords
variable region
antibody variable
diversification
promoting
promoting diversification
Prior art date
Application number
DK18750887.4T
Other languages
English (en)
Inventor
Keisuke Niikura
Yosuke Kamimura
Original Assignee
Chiome Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiome Bioscience Inc filed Critical Chiome Bioscience Inc
Application granted granted Critical
Publication of DK3581645T3 publication Critical patent/DK3581645T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0635B lymphocytes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23Immunoglobulins specific features characterized by taxonomic origin from birds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
DK18750887.4T 2017-02-10 2018-02-09 Fremgangsmåde til at fremme diversifikation af en antistof variabel region DK3581645T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017023001 2017-02-10
PCT/JP2018/004697 WO2018147432A1 (ja) 2017-02-10 2018-02-09 抗体可変領域の多様化を促進する方法

Publications (1)

Publication Number Publication Date
DK3581645T3 true DK3581645T3 (da) 2021-11-15

Family

ID=63106932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18750887.4T DK3581645T3 (da) 2017-02-10 2018-02-09 Fremgangsmåde til at fremme diversifikation af en antistof variabel region

Country Status (7)

Country Link
US (2) US11572402B2 (da)
EP (2) EP3974521A1 (da)
JP (2) JP7071740B2 (da)
CN (1) CN110291191B (da)
DK (1) DK3581645T3 (da)
ES (1) ES2895641T3 (da)
WO (1) WO2018147432A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109890842B (zh) * 2016-09-30 2023-12-22 凯奥目生物科学株式会社 抗体的取得方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122339B2 (en) 1998-10-09 2006-10-17 Medical Research Council Method for generating diversity
US20050246782A1 (en) * 2002-03-22 2005-11-03 Origen Therapeutics Transgenic aves producing human polyclonal antibodies
EP1536004B1 (en) 2002-07-30 2010-12-01 Riken Method of promoting homologous recombination of somatic cells and method of constructing specific antibody
AU2002343870A1 (en) 2002-11-07 2004-06-07 Kumamoto Technology And Industry Foundation Transgenic mammal carrying ganp and utilization thereof
JP4487068B2 (ja) 2004-10-12 2010-06-23 国立大学法人 岡山大学 細胞の遺伝子変異機能の制御による変異タンパク質の作製方法
JP2008099602A (ja) 2006-10-19 2008-05-01 Institute Of Physical & Chemical Research 抗体遺伝子の可変領域における変異部位の分布状況の調節法
ES2628973T3 (es) 2007-05-31 2017-08-04 University Of Washington Mutagénesis inducible de genes diana
JP2009060850A (ja) 2007-09-06 2009-03-26 Okayama Univ B細胞の抗体遺伝子変異様式の転換方法
SG196798A1 (en) * 2008-12-09 2014-02-13 Genentech Inc Anti-pd-l1 antibodies and their use to enhance t-cell function
US9719099B2 (en) 2012-08-10 2017-08-01 E I Du Pont De Nemours And Company Soybean CCP1 promoter and its use in constitutive expression of transgenic genes in plants
ES2728854T3 (es) 2013-02-06 2019-10-29 Univ Yokohama City Anticuerpo anti-semaforina 3A y tratamiento de enfermedad de Alzheimer y enfermedades inmunitarias inflamatorias usando el mismo
CN112877292A (zh) 2014-05-02 2021-06-01 凯奥目生物科学株式会社 产生人抗体的细胞

Also Published As

Publication number Publication date
CN110291191B (zh) 2023-09-12
EP3974521A1 (en) 2022-03-30
EP3581645A4 (en) 2020-12-16
JP7071740B2 (ja) 2022-05-19
US20190359691A1 (en) 2019-11-28
JP2022103201A (ja) 2022-07-07
EP3581645A1 (en) 2019-12-18
JPWO2018147432A1 (ja) 2019-11-21
WO2018147432A1 (ja) 2018-08-16
ES2895641T3 (es) 2022-02-22
CN110291191A (zh) 2019-09-27
US11572402B2 (en) 2023-02-07
US20230220049A1 (en) 2023-07-13
EP3581645B1 (en) 2021-09-01

Similar Documents

Publication Publication Date Title
DK3277717T3 (da) En hidtil ukendt il33-form, muterede former af il33, antistoffer, assays og fremgangsmåder til anvendelse deraf
DK3565844T3 (da) Fremgangsmåder til behandling af cancer med anti-PD-1-antistoffer
CL2018000370A1 (es) Nuevos anticuerpos anti-pd-1
DK3455257T3 (da) Anti-pd-l1-antistoffer
DK3315610T3 (da) Fremgangsmåde til fremstilling af fucosylerede oligosaccharider
DK3332006T3 (da) Hidtil ukendte anti-PD-L1-antistoffer
DK3478286T3 (da) Fremgangsmåder til behandling af ovariecancer
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
DK3441086T3 (da) Monoklonalt anti-PD-1-antistof
DK3292153T3 (da) Kombination af en cd30xcd16a-antistof med en anti-pd-1 antagonistisk antistof til behandling
DK3458100T3 (da) Selektiv reduktion af cystein-manipulerede antistoffer
DK3368683T3 (da) Fremgangsmåde til kvantifikationen af pd-l1
DK3515990T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3487443T3 (da) Fremgangsmåde til opmåling af en implantat-implantat-situation
DK3529227T3 (da) Fremgangsmåde til fremstilling af diener
DK3612845T3 (da) Fremgangsmåde til kontaktløs bestemmelse af flowparametre
DK3728585T3 (da) Hidtil ukendte fremgangsmåder til fremstilling af oligonukleotider
DK3384045T3 (da) Fremgangsmåde til bestemmelse af celleklonalitet
DK3277801T3 (da) Fremgangsmåde til fremstilling af otiske progenitorer
DK3226609T3 (da) Fremgangsmåde til scheduling af køretøj-til-køretøj-kommunikationer
DK3337820T3 (da) Forbedret fremgangsmåde til genfoldning af fragmenter af antistoffer
DK3567245T3 (da) Drift af vindmølle
DK3265439T3 (da) Fremgangsmåde til fremstilling af 3-chlor-2-vinylphenylsulfonater
ITUB20155097A1 (it) Anticorpi umanizzati anti-BAG3